Filter By

Recent Articles

Annual Meeting Abstract Submissions: The Why and How

Paloma Giangrande, PhD | December 07, 2022

We asked Paloma Giangrande, PhD, member-volunteer abstract reviewer and field expert, for her advice on submitting abstracts for the Annual Meeting. Submit by Feb. 3!

Annual Meeting 2023
Read Full Story

Free: Five-Minute Thesis Session & Contest

Live Friday, Dec. 9  | December 06, 2022

This Friday, Dec. 9, 1–3 p.m. CT, learn how to create an "elevator pitch" for your thesis and join our Five-Minute Thesis Challenge for a chance to present at the ASGCT Annual Meeting!

Read Full Story

10 Tips to Submit Your Abstract for the ASGCT Annual Meeting

Phil Tai, PhD | December 05, 2022

Wondering how to craft a great Annual Meeting abstract submission? Phil Tai, PhD, a member-volunteer abstract reviewer, shares his top 10 tips and considerations for researchers drafting their work. Submit by Feb. 3!

Annual Meeting 2023
Read Full Story

Free for Members: Research and Ethics of the Targeted Insertion of Genes into the Human Genome

Live Wednesday, Dec. 7 | December 01, 2022

Attend the expert-led session on Wednesday, Dec. 7, 1–3 p.m. CT, for free if you're a member. 

Read Full Story

World AIDS Day: A Look Back at the Puzzle

Renee Strong | December 01, 2022

On World AIDS day, Renee Strong, our diversity and inclusion program manager, reflects on her family's connection with the HIV/AIDS epidemic—and how the work of ASGCT member Dr. TJ Cradick became an essential part of solving the disease puzzle.

Member Story
Read Full Story

Developing a Gene Therapy for Charcot-Marie-Tooth Disease

November 30, 2022

We talked to Dr. Afrooz Rashnonejad about her experience working to develop a gene therapy for CMT1B and why patient organizations are so important in the process.

Member Story
Read Full Story

In Molecular Therapy: EBAG9 silencing exerts immune checkpoint function without adverse effects

Jessica Schneller, PhD | November 22, 2022

Wirges et al demonstrate that EBAG9 downregulation in murine T cells and human CAR T cells augmented the cytolytic activity of these cells against hematopoietic tumors in vitro and in vivo.

Read Dr. Schneller's debut summary for The Vector!

Molecular Therapy
Read Full Story

FDA Approves First Gene Therapy for Hemophilia B

Hans-Peter Kiem, MD, PhD | November 22, 2022

The approval of Hemgenix is the first of its kind for hemophilia B patients, who typically control the disease with regular infusions of the clotting factor they lack.

Read Full Story

Free for Members: Immunological Responses to AAV Gene Therapy in Neurological Compartments

Live Wednesday, Nov. 30 | November 21, 2022

Attend the expert-led session on Wednesday, Nov. 30, 1–3 p.m. CT, for free if you're a member. 

Read Full Story

Now On Demand: Explore the Ethical Limits of Gene Therapy

Hosted Friday, Nov. 18 | November 16, 2022

Bring your questions for Ben Hurlbut, PhD, and Krishanu Saha, PhD, who will help us break down the ethics of gene therapy.

Read Full Story

Submit Your Abstract to Present at the ASGCT 26th Annual Meeting

November 15, 2022

The #ASGCT23 call for abstracts is open Nov. 15, 2022, through Feb. 3, 2023.

Annual Meeting 2023
Read Full Story

Take Advantage of Global Outreach Opportunities

Jayandharan Rao, PhD | November 04, 2022

Dr. Rao talks about some of ASGCT's recent international efforts that you can share with colleagues, watch on demand, and keep in mind to register for in the future.

Read Full Story

Free for Members: Catch Events on Cellular Reprogramming (On Demand) & AAV Immune Responses (Nov. 30)

November 03, 2022

This month, register for Neural and Cardiac Cellular Reprogramming Nov. 16 and Immunological Responses to AAV Gene Therapy in Neurological Compartments Nov. 30.

Read Full Story

How to Be a Champion for Health Literacy

Ali Kujawski, MPH | October 25, 2022

During Health Literacy Awareness Month, learn how you can help others understand the health information they need.

Read Full Story

Hear David Baltimore, PhD on Giants of Gene Therapy

Alex Wendland, MSJ | October 25, 2022

Subscribe to the ASGCT Podcast Network to hear David Baltimore, PhD on the Nobel Prize, searching for answers on an HIV vaccine, and how gene therapy could change the course of history during his one-on-one conversation with ASGCT President Hans-Peter Kiem, MD, PhD.

Read Full Story

Q3: Multiple First Approvals for Gene, RNA Therapies

ASGCT Staff | October 21, 2022

More gene and RNA therapies were approved in Q3 than in each of the previous quarters for over a year.

Read Full Story

26th Annual Meeting

May 16-20 | Los Angeles, CA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.